about
Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data.Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyReport from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.Primary and recurrent diffuse astrocytomas: genomic profile comparison reveals acquisition of biologically relevant aberrationsRare congenital chromosomal aberration dic(X;Y)(p22.33;p11.32) in a patient with primary myelofibrosisTP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin.Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies.Derivative (6)t(1;6)(q22;p21) revealed in bone marrow cells by FISH 9 months before diagnosis of acute T-lymphoblastic leukemia.Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.Molecular cytogenetic analysis of dicentric chromosomes in acute myeloid leukemia.Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment.An unusual case of high hyperdiploid childhood ALL with cryptic BCR/ABL1 rearrangement.Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy.Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia.Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites.Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization.Rearrangement of 11q13.2 region in two patients with acute myeloid leukemia.From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype.CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage.Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q).CML patient with rare b 2 a 3 (e 13 a 3) variant of BCR-ABL transcript: complete molecular response to imatinib.Covert preleukemia driven by MLL gene fusion.Change in ploidy status from hyperdiploid to near-tetraploid in multiple myeloma associated with bortezomib/lenalidomide resistance.Backtracking of ALL to cord blood.Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene.International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene.ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia.A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemia.The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR.Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome.Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies
P50
Q33287677-674B9EAB-F898-486F-80A8-29F8063E66ACQ34080807-CD956A8B-074A-4250-AFFF-7F3C567DEA50Q35127974-B8E20E70-3735-4D57-84E7-3188223CD638Q36133050-7350C303-E992-4038-ABCC-88ED0C6C9B56Q36566055-785F4DD6-EC89-4823-9C96-B51FDEF84F6AQ37224321-126ED55F-EA16-48DC-9B95-49120F97B17DQ37392696-640AD3FA-7622-42AB-8005-2542BC58492FQ37768752-A519AB23-1FDA-4A43-866E-9DC46C3638BFQ38497622-E943307E-D2E5-48B7-864D-B7EB6325F351Q38507676-359E3266-73D4-479A-A0D1-1BC23D0D0068Q38753773-C9F43FC5-DBED-4F47-A13E-10CC64A2FA9DQ38798626-06E97BD8-F338-4154-A13B-88256B6C3094Q39608295-E21E229F-5C47-4215-923D-063392645C13Q39876893-6BC732EC-9264-43F3-897C-2263E8167B2AQ40018345-F1869F6E-721D-403D-861E-CFBB5FB1001FQ41032440-1B739A0D-4331-4ED7-AE50-2867BAD0250FQ41060122-08DDAF91-7EAE-4D5E-BAC6-93FDA10351A5Q41978063-62C7FBFD-295A-4B22-AAE8-CC568F536FEFQ43223973-BA7F4797-7CF8-466F-A6AE-6D17DC401318Q43410945-BD86C212-04C0-4945-93BB-D894875DEBF2Q43475554-6DC2982C-FC76-487E-B874-5249DA070D20Q44655661-FDCDDCC0-C1D4-420E-9008-12D6BCB5043EQ44973777-30C7D2EC-374D-4566-BDF5-FCCF0CF6C89CQ45405305-CE57E539-4EFD-424F-8C1B-8BBD171E4113Q45891227-29DFB879-1FCC-4195-80F7-6C5F3890B3F9Q46095097-72ECC88B-878D-4F66-83D1-DFF20CBDB480Q46474440-F98BAEFF-0E0F-4168-8CF4-003FE84D118BQ46489719-DD890DD0-D527-4080-8B11-B96E8F93FC33Q51116437-6C18E178-A098-421F-B182-1A01C9AC6E04Q51833840-079367E4-30E2-47AF-97D6-C4EFCAD17DE2Q52150633-5BDB2EB2-C118-4ADC-8505-61D9FF981182Q52803502-2764B398-D6A5-462C-9857-E78F6CDBC473Q53423040-A09309A6-E0DA-4E47-987A-3871417076E3Q53436085-8B32DCB0-173F-43A3-977C-A22B70E00920Q54393948-69247C45-C51F-459F-BB3A-7361EC7B5F7CQ54451461-797C1245-7C1B-4988-AC14-3A8AD321BF38Q54584511-9814465F-0650-4B87-B360-C8D85810118CQ54667181-D08EB7B7-6EDC-4C08-8C7E-5BD6A9FA7E49Q54778798-86B37101-9CC1-4AF6-9614-7A7861E4844CQ56802679-19C0F56F-E3BF-47CC-A950-5DFF75D4CB1C
P50
description
cytogenetička, molekulární bioložka, hematoložka
@cs
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Zuzana Zemanová
@ast
Zuzana Zemanová
@cs
Zuzana Zemanová
@en
Zuzana Zemanová
@es
Zuzana Zemanová
@fr
Zuzana Zemanová
@nl
Zuzana Zemanová
@sk
Zuzana Zemanová
@sl
type
label
Zuzana Zemanová
@ast
Zuzana Zemanová
@cs
Zuzana Zemanová
@en
Zuzana Zemanová
@es
Zuzana Zemanová
@fr
Zuzana Zemanová
@nl
Zuzana Zemanová
@sk
Zuzana Zemanová
@sl
altLabel
Koudelova Z
@en
Koudelova Zuzana
@en
Koudelová Zuzana
@en
Zemanova Z
@en
Zemanová Zuzana
@en
Zuzana Koudelová
@cs
Zuzana Zemanova
@en
prefLabel
Zuzana Zemanová
@ast
Zuzana Zemanová
@cs
Zuzana Zemanová
@en
Zuzana Zemanová
@es
Zuzana Zemanová
@fr
Zuzana Zemanová
@nl
Zuzana Zemanová
@sk
Zuzana Zemanová
@sl
P106
P214
P1053
D-8041-2017
P1153
6508292820
7003710364
P21
P214
P31
P3829
P496
0000-0002-7538-6601
P569
1962-10-26T00:00:00Z
P691
nlk20050170627